ECM
AMAG

ETrade Capital Management’s AMAG Pharmaceuticals AMAG Stock Holding History

ETrade Capital Management’s Portfolio AMAG Stock Details AMAG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-18,054
Closed -$545K – 489
2015
Q4 		$545K Buy
18,054
+5,941
+49% +$192K 0.03% 313
2015
Q3 		$481K Buy
12,113
+2,687
+29% +$167K 0.03% 306
2015
Q2 		$651K Buy
+9,426
New +$593K 0.04% 249

Other funds holding AMAG

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
PI
Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
SIM
Stelliam Investment Management New York $404M AUM 5.1% 1-Year Est. Return

ETrade Capital Management's AMAG Position: Q1 2016 in Review

ETrade Capital Management sold out of AMAG Pharmaceuticals (AMAG) in Q1 2016, closing a stake of 18,054 shares — an estimated $545K sold.

ETrade Capital Management first reported a position in AMAG in Q2 2015 and held it in 3 quarters. The position peaked at $651K in Q2 2015. 185 funds tracked by Wall St. Rank hold AMAG as of Q1 2016.

  • ETrade Capital Management reported no remaining AMAG Pharmaceuticals position as of Q1 2016 after selling out during the quarter.
  • ETrade Capital Management sold 18,054 AMAG Pharmaceuticals shares in Q1 2016, an estimated $545K.
  • ETrade Capital Management first reported a position in AMAG Pharmaceuticals in Q2 2015 and held it in 3 quarters.
  • ETrade Capital Management's AMAG Pharmaceuticals position peaked at $651K in Q2 2015.
  • 185 funds tracked by Wall St. Rank held AMAG Pharmaceuticals as of Q1 2016.

Based on ETrade Capital Management's 13F filing for Q1 2016, filed 16 May 2016.